Vaxcyte, Inc.
PCVXNASDAQHealthcare● Active
$46.33
$-1.03(-2.17%)
Market Cap$6.7B
P/E Ratio—
52W High$65
52W Low$29.08
Vaxcyte, Inc.（PCVX）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PCVX · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.77B) | ($0.46B) | ($0.40B) | ($0.22B) | ($0.10B) |
| Depreciation & Amort. | $0.02B | $0.02B | $0.01B | $0.01B | $0.00B |
| Stock-Based Comp. | $0.14B | $0.08B | $0.05B | $0.02B | $0.01B |
| Change in Working Capital | $0.02B | ($0.05B) | $0.08B | $0.01B | ($0.04B) |
| Net Cash from Operations | ($0.66B) | ($0.45B) | ($0.30B) | ($0.17B) | ($0.12B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.02B) | ($0.07B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | ($1.21B) | ($3.09B) | ($1.33B) | ($0.10B) | ($0.34B) |
| Sales of Investments | $1.71B | $1.20B | $0.62B | $0.18B | $0.13B |
| Net Cash from Investing | $0.44B | ($2.01B) | ($0.77B) | $0.07B | ($0.21B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | $2.45B | $0.64B | $0.86B | $0.02B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.67B) | ($0.48B) | ($0.36B) | ($0.18B) | ($0.13B) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Vaxcyte, Inc.
关于Vaxcyte, Inc.（PCVX）现金流量表
Vaxcyte, Inc. 2025财年经营活动现金流($0.66B)，自由现金流($0.67B)（FCF利润率—），资本支出($0.01B)。
常见问题
PCVX · 4 问Vaxcyte, Inc. 2025财年自由现金流($0.67B)，同比down40.9%。
PCVX free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10